# BEQALZI
> **NDA220711** · New Drug Application · Sponsor: BEONE MEDICINES USA · Approved 2026-05-13
## Drug
- **FDA Application Number:** NDA220711
- **Application type:** New Drug Application
- **Brand name:** BEQALZI
- **Generic name:** Sonrotoclax
- **Active ingredients:** SONROTOCLAX
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BEONE MEDICINES USA
- **First approval:** 2026-05-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220711)
---
*MORVS · CC0 1.0*